ID

30391

Description

Epstein-Barr Virus (EBV)-Specific T Cells as Therapy for Relapsed/Refractory EBV-positive Lymphomas; ODM derived from: https://clinicaltrials.gov/show/NCT00779337

Lien

https://clinicaltrials.gov/show/NCT00779337

Mots-clés

Versions (1)
  1. 01/06/2018 01/06/2018 -
Détendeur de droits

See clinicaltrials.gov

Téléchargé le

1 juin 2018

DOI

Pour une demande vous connecter.

Licence

Creative Commons BY 4.0
Modèle Commentaires :

Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.

Retour au modèle Commentaires
Groupe Item commentaires pour :

Item commentaires pour :

Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.

Eligibility Lymphoma NCT00779337

Anglais

Eligibility Lymphoma NCT00779337

1 Formulaires  
  1. StudyEvent: Eligibility
    1. Eligibility Lymphoma NCT00779337
Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI
C1512693
informed consent.
Description

Informed Consent

Type de données

boolean

Alias
UMLS CUI [1]
C0021430
ebv-positive lymphoma as determined by in situ hybridization or equivalent (excluding burkitts lymphoma).
Description

Lymphoma Epstein-Barr Virus Positive In Situ Hybridization | In Situ Hybridization Equivalent | Burkitt Lymphoma Excluded

Type de données

boolean

Alias
UMLS CUI [1,1]
C0024299
UMLS CUI [1,2]
C0014644
UMLS CUI [1,3]
C1514241
UMLS CUI [1,4]
C0162788
UMLS CUI [2,1]
C0162788
UMLS CUI [2,2]
C0205163
UMLS CUI [3,1]
C0006413
UMLS CUI [3,2]
C0332196
age 18 years or older.
Description

Age

Type de données

boolean

Alias
UMLS CUI [1]
C0001779
ecog performance status 1, 2 or 3
Description

ECOG performance status

Type de données

boolean

Alias
UMLS CUI [1]
C1520224
life expectancy of at least 6 months.
Description

Life Expectancy

Type de données

boolean

Alias
UMLS CUI [1]
C0023671
measurable disease: either relapsing, partially responsive, refractory or progressive disease, includes disease detected either by clinical examination, radiographic evaluation (including ct scans, and at physician's discretion by functional imaging), or a persistently detectable plasma ebv viral load.
Description

Measurable Disease | Recurrent disease | Partial response | Refractory Disease | Progressive Disease | Measurable Disease Clinical examination | Measurable Disease Radiography | Measurable Disease CT scan | Measurable Disease Functional Imaging | Plasma EBV Viral load Persistent

Type de données

boolean

Alias
UMLS CUI [1]
C1513041
UMLS CUI [2]
C0277556
UMLS CUI [3]
C1521726
UMLS CUI [4]
C1514815
UMLS CUI [5]
C1335499
UMLS CUI [6,1]
C1513041
UMLS CUI [6,2]
C1456356
UMLS CUI [7,1]
C1513041
UMLS CUI [7,2]
C0034571
UMLS CUI [8,1]
C1513041
UMLS CUI [8,2]
C0040405
UMLS CUI [9,1]
C1513041
UMLS CUI [9,2]
C1517324
UMLS CUI [10,1]
C0032105
UMLS CUI [10,2]
C0014644
UMLS CUI [10,3]
C0376705
UMLS CUI [10,4]
C0205322
no chemotherapy / radiotherapy and/or antibody therapy for at least 2 weeks prior to anticipated date of first infusion.
Description

Chemotherapy Absent | Therapeutic radiology procedure Absent | Antibody therapy Absent

Type de données

boolean

Alias
UMLS CUI [1,1]
C0392920
UMLS CUI [1,2]
C0332197
UMLS CUI [2,1]
C1522449
UMLS CUI [2,2]
C0332197
UMLS CUI [3,1]
C0281176
UMLS CUI [3,2]
C0332197
Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251
ebv negative tumour
Description

Neoplasm Epstein-Barr Virus Negative

Type de données

boolean

Alias
UMLS CUI [1,1]
C0027651
UMLS CUI [1,2]
C0014644
UMLS CUI [1,3]
C1513916
presence of detectable malignant cells in the peripheral circulation by flow cytometry or morphology
Description

Malignant cells Detectable Peripheral circulation Flow Cytometry | Malignant cells Detectable Peripheral circulation Morphanalysis

Type de données

boolean

Alias
UMLS CUI [1,1]
C0334227
UMLS CUI [1,2]
C3830527
UMLS CUI [1,3]
C0425710
UMLS CUI [1,4]
C0016263
UMLS CUI [2,1]
C0334227
UMLS CUI [2,2]
C3830527
UMLS CUI [2,3]
C0425710
UMLS CUI [2,4]
C0411862
serious infection within the past 28 days that has not adequately responded to therapy
Description

Communicable Disease Serious | Disease Response Inadequate

Type de données

boolean

Alias
UMLS CUI [1,1]
C0009450
UMLS CUI [1,2]
C0205404
UMLS CUI [2,1]
C1704632
UMLS CUI [2,2]
C0205412
pregnancy, or unwilling to use adequate contraception
Description

Pregnancy | Contraceptive methods Unwilling

Type de données

boolean

Alias
UMLS CUI [1]
C0032961
UMLS CUI [2,1]
C0700589
UMLS CUI [2,2]
C0558080
serology (taken within 3 months of ctl release date) indicating active hbv or hcv infection, positive serology for hiv i&ii, htlv1 or syphilis
Description

Serology positive Hepatitis B | Serology positive Hepatitis C | Serology positive HIV-1 | Serology positive HIV-2 | Serology positive Syphilis

Type de données

boolean

Alias
UMLS CUI [1,1]
C0242089
UMLS CUI [1,2]
C0019163
UMLS CUI [2,1]
C0242089
UMLS CUI [2,2]
C0019196
UMLS CUI [3,1]
C0242089
UMLS CUI [3,2]
C0019704
UMLS CUI [4,1]
C0242089
UMLS CUI [4,2]
C0019707
UMLS CUI [5,1]
C0242089
UMLS CUI [5,2]
C0039128
negative serology for ebv
Description

Serology negative Epstein-Barr Virus

Type de données

boolean

Alias
UMLS CUI [1,1]
C0919674
UMLS CUI [1,2]
C0014644
psychiatric, addictive or any condition which may compromise the ability to participate in this trial
Description

Mental condition compromises Study Subject Participation Status | Addictive Behavior compromises Study Subject Participation Status | Condition compromises Study Subject Participation Status

Type de données

boolean

Alias
UMLS CUI [1,1]
C3840291
UMLS CUI [1,2]
C2945640
UMLS CUI [1,3]
C2348568
UMLS CUI [2,1]
C0085281
UMLS CUI [2,2]
C2945640
UMLS CUI [2,3]
C2348568
UMLS CUI [3,1]
C0348080
UMLS CUI [3,2]
C2945640
UMLS CUI [3,3]
C2348568
Retour au début de la page

Similar models

Eligibility Lymphoma NCT00779337

1 Formulaires
  1. StudyEvent: Eligibility
    1. Eligibility Lymphoma NCT00779337
Name
Type
Description | Question | Decode (Coded Value)
Type de données
Alias
Item Group
C1512693 (UMLS CUI)
Informed Consent
Item
informed consent.
boolean
C0021430 (UMLS CUI [1])
Lymphoma Epstein-Barr Virus Positive In Situ Hybridization | In Situ Hybridization Equivalent | Burkitt Lymphoma Excluded
Item
ebv-positive lymphoma as determined by in situ hybridization or equivalent (excluding burkitts lymphoma).
boolean
C0024299 (UMLS CUI [1,1])
C0014644 (UMLS CUI [1,2])
C1514241 (UMLS CUI [1,3])
C0162788 (UMLS CUI [1,4])
C0162788 (UMLS CUI [2,1])
C0205163 (UMLS CUI [2,2])
C0006413 (UMLS CUI [3,1])
C0332196 (UMLS CUI [3,2])
Age
Item
age 18 years or older.
boolean
C0001779 (UMLS CUI [1])
ECOG performance status
Item
ecog performance status 1, 2 or 3
boolean
C1520224 (UMLS CUI [1])
Life Expectancy
Item
life expectancy of at least 6 months.
boolean
C0023671 (UMLS CUI [1])
Measurable Disease | Recurrent disease | Partial response | Refractory Disease | Progressive Disease | Measurable Disease Clinical examination | Measurable Disease Radiography | Measurable Disease CT scan | Measurable Disease Functional Imaging | Plasma EBV Viral load Persistent
Item
measurable disease: either relapsing, partially responsive, refractory or progressive disease, includes disease detected either by clinical examination, radiographic evaluation (including ct scans, and at physician's discretion by functional imaging), or a persistently detectable plasma ebv viral load.
boolean
C1513041 (UMLS CUI [1])
C0277556 (UMLS CUI [2])
C1521726 (UMLS CUI [3])
C1514815 (UMLS CUI [4])
C1335499 (UMLS CUI [5])
C1513041 (UMLS CUI [6,1])
C1456356 (UMLS CUI [6,2])
C1513041 (UMLS CUI [7,1])
C0034571 (UMLS CUI [7,2])
C1513041 (UMLS CUI [8,1])
C0040405 (UMLS CUI [8,2])
C1513041 (UMLS CUI [9,1])
C1517324 (UMLS CUI [9,2])
C0032105 (UMLS CUI [10,1])
C0014644 (UMLS CUI [10,2])
C0376705 (UMLS CUI [10,3])
C0205322 (UMLS CUI [10,4])
Chemotherapy Absent | Therapeutic radiology procedure Absent | Antibody therapy Absent
Item
no chemotherapy / radiotherapy and/or antibody therapy for at least 2 weeks prior to anticipated date of first infusion.
boolean
C0392920 (UMLS CUI [1,1])
C0332197 (UMLS CUI [1,2])
C1522449 (UMLS CUI [2,1])
C0332197 (UMLS CUI [2,2])
C0281176 (UMLS CUI [3,1])
C0332197 (UMLS CUI [3,2])
Item Group
C0680251 (UMLS CUI)
Neoplasm Epstein-Barr Virus Negative
Item
ebv negative tumour
boolean
C0027651 (UMLS CUI [1,1])
C0014644 (UMLS CUI [1,2])
C1513916 (UMLS CUI [1,3])
Malignant cells Detectable Peripheral circulation Flow Cytometry | Malignant cells Detectable Peripheral circulation Morphanalysis
Item
presence of detectable malignant cells in the peripheral circulation by flow cytometry or morphology
boolean
C0334227 (UMLS CUI [1,1])
C3830527 (UMLS CUI [1,2])
C0425710 (UMLS CUI [1,3])
C0016263 (UMLS CUI [1,4])
C0334227 (UMLS CUI [2,1])
C3830527 (UMLS CUI [2,2])
C0425710 (UMLS CUI [2,3])
C0411862 (UMLS CUI [2,4])
Communicable Disease Serious | Disease Response Inadequate
Item
serious infection within the past 28 days that has not adequately responded to therapy
boolean
C0009450 (UMLS CUI [1,1])
C0205404 (UMLS CUI [1,2])
C1704632 (UMLS CUI [2,1])
C0205412 (UMLS CUI [2,2])
Pregnancy | Contraceptive methods Unwilling
Item
pregnancy, or unwilling to use adequate contraception
boolean
C0032961 (UMLS CUI [1])
C0700589 (UMLS CUI [2,1])
C0558080 (UMLS CUI [2,2])
Serology positive Hepatitis B | Serology positive Hepatitis C | Serology positive HIV-1 | Serology positive HIV-2 | Serology positive Syphilis
Item
serology (taken within 3 months of ctl release date) indicating active hbv or hcv infection, positive serology for hiv i&ii, htlv1 or syphilis
boolean
C0242089 (UMLS CUI [1,1])
C0019163 (UMLS CUI [1,2])
C0242089 (UMLS CUI [2,1])
C0019196 (UMLS CUI [2,2])
C0242089 (UMLS CUI [3,1])
C0019704 (UMLS CUI [3,2])
C0242089 (UMLS CUI [4,1])
C0019707 (UMLS CUI [4,2])
C0242089 (UMLS CUI [5,1])
C0039128 (UMLS CUI [5,2])
Serology negative Epstein-Barr Virus
Item
negative serology for ebv
boolean
C0919674 (UMLS CUI [1,1])
C0014644 (UMLS CUI [1,2])
Mental condition compromises Study Subject Participation Status | Addictive Behavior compromises Study Subject Participation Status | Condition compromises Study Subject Participation Status
Item
psychiatric, addictive or any condition which may compromise the ability to participate in this trial
boolean
C3840291 (UMLS CUI [1,1])
C2945640 (UMLS CUI [1,2])
C2348568 (UMLS CUI [1,3])
C0085281 (UMLS CUI [2,1])
C2945640 (UMLS CUI [2,2])
C2348568 (UMLS CUI [2,3])
C0348080 (UMLS CUI [3,1])
C2945640 (UMLS CUI [3,2])
C2348568 (UMLS CUI [3,3])
Retour au début de la page 

Contact

Utilisez ce formulaire pour les retours, les questions et les améliorations suggérées.

Les champs marqués d’un * sont obligatoires.

Aide

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial